Evidence map›Paper›PMID 32508938›Full record

ReviewCellular & molecular biology letters2020

Role of angiotensin-converting enzyme in myeloid cell immune responses.

Duo-Yao Cao, Suguru Saito, Luciana C Veiras, Derick Okwan-Duodu, Ellen A Bernstein, Jorge F Giani, Kenneth E Bernstein, Zakir Khan

Open access · goldAbstract readReview
In one paragraph

Review in Cellular & molecular biology letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Duo-Yao CaoDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048 USA.
Suguru SaitoDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048 USA.
Luciana C VeirasDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048 USA.
Derick Okwan-DuoduDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048 USA.
Ellen A BernsteinDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048 USA.
Jorge F GianiDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048 USA.
Kenneth E BernsteinDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048 USA.
Zakir KhanDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048 USA.ORCID 0000-0002-7944-491X
Cedars-Sinai Medical Center · US

Funding

The Role of Inflammation in Cardiovascular DiseaseP01HL129941 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNSTEIN, KENNETH E · 2016 to 2020
$12.4M
Supplemental Grant: Increased neutrophil function in Alzheimer's diseaseR01AI134714 · NIAID · CEDARS-SINAI MEDICAL CENTER · PI BERNSTEIN, KENNETH E · 2018 to 2021
$2.1M
The role of angiotensin-converting enzyme in renal inflammation, kidney injury and sodium retention during diabetic nephropathyR01HL142672 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI BERNSTEIN, KENNETH E · 2018 to 2021
$1.7M
NHLBI NIH HHS P01 HL129941NHLBI NIH HHS R01 HL142672NIAID NIH HHS R01 AI134714
6 · The paper itself

Abstract

Angiotensin-converting enzyme (ACE), a dicarboxypeptidase, plays a major role in the regulation of blood pressure by cleaving angiotensin I into angiotensin II (Ang II), a potent vasoconstrictor. Because of its wide substrate specificity and tissue distribution, ACE affects many diverse biological processes. In inflammatory diseases, including granuloma, atherosclerosis, chronic kidney disease and bacterial infection, ACE expression gets upregulated in immune cells, especially in myeloid cells. With increasing evidences connecting ACE functions to the pathogenesis of these acquired diseases, it is suggested that ACE plays a vital role in immune functions. Recent studies with mouse models of bacterial infection and tumor suggest that ACE plays an important role in the immune responses of myeloid cells. Inhibition of ACE suppresses neutrophil immune response to bacterial infection. In contrast, ACE overexpression in myeloid cells strongly induced bacterial and tumor resistance in mice. A detailed biochemical understanding of how ACE activates myeloid cells and which ACE peptide(s) (substrate or product) mediate these effects could lead to the development of novel therapies for boosting immunity against a variety of stimuli, including bacterial infection and tumor.

Indexed as

Adaptive ImmunityAnimalsBacterial InfectionsHematopoiesisHumansInflammationMiceMyeloid CellsNeoplasmsPeptidyl-Dipeptidase APeptidyl-Dipeptidase AAngiotensin-converting enzymeDendritic cellsHematopoiesisImmune responseMacrophagesMelanomaMethicillin-resistant Staphylococcus aureus (MRSA)MHC class I antigen presentationMyeloid cellsNeutrophils

Identifiers

PMID32508938
PMCPMC7249647
OpenAlexW3030235333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.